Focal Laser Ablation of Prostate Cancer
NCT: NCT04305925 · COMPLETED
Brief Summary
The primary objective of this study is to evaluate the safety and feasibility of Magnetic-Resonance(MR)-ultrasound image fusion-guided transrectal-based focal laser ablation (FLA) of prostate cancer using the Orion System, an investigational laser-based interstitial irradiation/thermal soft-tissue ablation system. Safety and feasibility will be determined by analyzing the number, type, and severity of adverse events.
Frequently Asked Questions
What is Focal Laser Ablation of Prostate Cancer?
Focal Laser Ablation of Prostate Cancer is a clinical trial registered under NCT04305925. Current status: COMPLETED.
What is the status of NCT04305925?
The current status of NCT04305925 (Focal Laser Ablation of Prostate Cancer) is: COMPLETED.
When did Focal Laser Ablation of Prostate Cancer start?
Focal Laser Ablation of Prostate Cancer started on 2020-01-30.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.